Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis

Condition:   Moderate to Severe Active Rheumatoid Arthritis Interventions:   Drug: HS628+MTX;   Drug: Actemra +MTX Sponsor:   Zhejiang Hisun Pharmaceutical Co. Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials